BNP Paribas Financial Markets
SCMP

BNP Paribas Financial Markets’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

BNP Paribas Financial Markets’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,387
Closed -$186K – 4430
2017
Q4 		$186K Sell
10,387
-10,092
-49% -$124K ﹤0.01% 2997
2017
Q3 		$242K Sell
20,479
-4,815
-19% -$54K ﹤0.01% 2366
2017
Q2 		$266K Buy
25,294
+17,078
+208% +$174K ﹤0.01% 2276
2017
Q1 		$90.4K Buy
8,216
+3,368
+69% +$39.1K ﹤0.01% 2529
2016
Q4 		$65.7K Buy
4,848
+3,074
+173% +$42.9K ﹤0.01% 2714
2016
Q3 		$21.8K Buy
1,774
+730
+70% +$8.6K ﹤0.01% 2844
2016
Q2 		$11.5K Buy
1,044
+1,026
+5,700% +$11.5K ﹤0.01% 2851
2016
Q1 		$197 Sell
18
-5,318
-100% -$67.2K ﹤0.01% 2597
2015
Q4 		$92.3K Buy
5,336
+23
+0.4% +$412 ﹤0.01% 2385
2015
Q3 		$106K Buy
5,313
+3,244
+157% +$74.4K ﹤0.01% 2355
2015
Q2 		$34K Buy
2,069
+1,654
+399% +$28.7K ﹤0.01% 2721
2015
Q1 		$6.46K Buy
+415
New +$6.43K ﹤0.01% 3008
2014
Q4 		– Sell
-1,219
Closed -$7.92K – 3729
2014
Q3 		$7.92K Buy
1,219
+1,143
+1,504% +$7.59K ﹤0.01% 3694
2014
Q2 		$524 Sell
76
-514
-87% -$3.63K ﹤0.01% 3577
2014
Q1 		$4.08K Sell
590
-127
-18% -$1.09K ﹤0.01% 2458
2013
Q4 		$6.74K Buy
+717
New +$5.12K ﹤0.01% 2906

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

BNP Paribas Financial Markets's SCMP Position: Q1 2018 in Review

BNP Paribas Financial Markets sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 10,387 shares — an estimated $186K sold.

BNP Paribas Financial Markets first reported a position in SCMP in Q4 2013 and held it in 16 quarters. The position peaked at $266K in Q2 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • BNP Paribas Financial Markets reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 10,387 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $186K.
  • BNP Paribas Financial Markets first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2013 and held it in 16 quarters.
  • BNP Paribas Financial Markets's Sucampo Pharmaceuticals, Inc. position peaked at $266K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2018, filed 11 May 2018.